BIM
UTHR icon

BRC Investment Management’s United Therapeutics UTHR Stock Holding History

BRC Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,793
Closed -$751K – 144
2015
Q4 		$751K Buy
+4,793
New +$698K 0.11% 65

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BRC Investment Management's UTHR Position: Q1 2016 in Review

BRC Investment Management sold out of United Therapeutics (UTHR) in Q1 2016, closing a stake of 4,793 shares — an estimated $751K sold.

BRC Investment Management first reported a position in UTHR in Q4 2015 and held it in 1 quarter. The position peaked at $751K in Q4 2015. 398 funds tracked by Wall St. Rank hold UTHR as of Q1 2016.

  • BRC Investment Management reported no remaining United Therapeutics position as of Q1 2016 after selling out during the quarter.
  • BRC Investment Management sold 4,793 United Therapeutics shares in Q1 2016, an estimated $751K.
  • BRC Investment Management first reported a position in United Therapeutics in Q4 2015 and held it in 1 quarter.
  • BRC Investment Management's United Therapeutics position peaked at $751K in Q4 2015.
  • 398 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2016.

Based on BRC Investment Management's 13F filing for Q1 2016, filed 26 Apr 2016.